Manufacturing & Supply Chain

Peter Brabeck-Letmathe, chairman of Nestlé, has been diagnosed with an illness which is curable but requires periodic medical treatment over the next six months.

This does not affect Mr Brabeck-Letmathe’s ability to carry out his role as chairman of the Nestlé board of directors and he will continue to fully exercise his duties during the treatment period.